VNUS Medical Technologies
Since 1995, the pioneer in minimally invasive treatments for venous diseases, delivering the life-changing Closure System to hundreds of thousands globally.
Since 1995, the pioneer in minimally invasive treatments for venous diseases, delivering the life-changing Closure System to hundreds of thousands globally.
VNUS Medical Technologies is a trailblazing company launched in 1995 that specializes in pioneering minimally invasive treatments for venous diseases. The company's acclaimed Closure System has transformed the lives of hundreds of thousands globally, effectively addressing symptoms of venous reflux. Notably, the Closure System received regulatory approval in the United States in March 1999, following its introduction in Europe in 1998. The company has seen substantial success, with over 500,000 patients benefiting from the transformative Closure procedure. Recognized studies have highlighted the noteworthy advantages it provides to patients with venous disease. In line with its mission, VNUS Medical Technologies received support from Bay City Capital in a Venture Round investment in 01 March 1999.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 1 |
|
01 Mar 1999 |
No recent news or press coverage available for VNUS Medical Technologies.
We care about your data, and we'd love to use cookies make your experience better.